Danita M. Yoerger Sanborn, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arrhythmogenic Right Ventricular Dysplasia | 7 | 2023 | 162 | 0.720 |
Why?
|
| Cardiomyopathy, Hypertrophic | 9 | 2012 | 1311 | 0.490 |
Why?
|
| Heart Valve Diseases | 3 | 2024 | 1047 | 0.370 |
Why?
|
| Ethanol | 6 | 2009 | 1323 | 0.340 |
Why?
|
| Sclerosing Solutions | 3 | 2006 | 79 | 0.330 |
Why?
|
| Brain Ischemia | 1 | 2022 | 3127 | 0.310 |
Why?
|
| Mitral Valve Insufficiency | 4 | 2023 | 1419 | 0.310 |
Why?
|
| Echocardiography | 14 | 2024 | 4981 | 0.300 |
Why?
|
| Stroke | 5 | 2022 | 9952 | 0.290 |
Why?
|
| Ventricular Dysfunction, Right | 3 | 2023 | 615 | 0.290 |
Why?
|
| Mitral Valve | 5 | 2023 | 1486 | 0.260 |
Why?
|
| Heart Septum | 4 | 2006 | 303 | 0.200 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2014 | 269 | 0.200 |
Why?
|
| Atrial Fibrillation | 5 | 2022 | 5209 | 0.200 |
Why?
|
| Esters | 1 | 2002 | 211 | 0.190 |
Why?
|
| Septal Occluder Device | 1 | 2019 | 126 | 0.160 |
Why?
|
| Fatty Acids | 2 | 2006 | 1804 | 0.160 |
Why?
|
| Ventricular Function, Right | 3 | 2023 | 610 | 0.150 |
Why?
|
| Running | 2 | 2006 | 483 | 0.140 |
Why?
|
| Myocardium | 6 | 2023 | 4700 | 0.140 |
Why?
|
| Viridans Streptococci | 1 | 2006 | 16 | 0.140 |
Why?
|
| Vascular Fistula | 1 | 2006 | 50 | 0.130 |
Why?
|
| Atrial Appendage | 1 | 2019 | 292 | 0.130 |
Why?
|
| Heart Atria | 3 | 2020 | 1346 | 0.130 |
Why?
|
| Solvents | 1 | 2006 | 292 | 0.120 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2006 | 2128 | 0.120 |
Why?
|
| Sclerotherapy | 1 | 2006 | 181 | 0.120 |
Why?
|
| Ventricular Function | 1 | 2006 | 408 | 0.120 |
Why?
|
| Fistula | 1 | 2006 | 214 | 0.120 |
Why?
|
| Heart Block | 1 | 2005 | 392 | 0.110 |
Why?
|
| Physical Endurance | 1 | 2006 | 363 | 0.110 |
Why?
|
| Physical Exertion | 1 | 2006 | 662 | 0.110 |
Why?
|
| Ventricular Septal Rupture | 1 | 2003 | 17 | 0.110 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2003 | 48 | 0.110 |
Why?
|
| Heart | 2 | 2024 | 4393 | 0.110 |
Why?
|
| Patient Selection | 1 | 2014 | 4279 | 0.100 |
Why?
|
| Electrocardiography, Ambulatory | 3 | 2010 | 578 | 0.100 |
Why?
|
| Streptococcal Infections | 1 | 2006 | 617 | 0.100 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2004 | 461 | 0.100 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2010 | 1572 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 2022 | 1570 | 0.090 |
Why?
|
| Warfarin | 1 | 2019 | 1518 | 0.090 |
Why?
|
| Ventricular Fibrillation | 2 | 2009 | 539 | 0.090 |
Why?
|
| Mitral Valve Stenosis | 1 | 2003 | 348 | 0.090 |
Why?
|
| Sports | 1 | 2006 | 700 | 0.090 |
Why?
|
| Dyspnea | 2 | 2004 | 1353 | 0.080 |
Why?
|
| Quality Improvement | 1 | 2014 | 3835 | 0.080 |
Why?
|
| Aorta | 1 | 2006 | 2039 | 0.080 |
Why?
|
| Heart Ventricles | 3 | 2006 | 3812 | 0.080 |
Why?
|
| Anticoagulants | 2 | 2022 | 4897 | 0.070 |
Why?
|
| Quantitative Trait Loci | 1 | 2005 | 2101 | 0.070 |
Why?
|
| Esterification | 2 | 2006 | 39 | 0.070 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2009 | 247 | 0.070 |
Why?
|
| Aortic Valve | 1 | 2006 | 1996 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2006 | 276 | 0.060 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2012 | 866 | 0.060 |
Why?
|
| Hospitalization | 2 | 2022 | 10789 | 0.060 |
Why?
|
| Humans | 37 | 2024 | 760613 | 0.060 |
Why?
|
| Probucol | 1 | 2003 | 25 | 0.060 |
Why?
|
| Embolization, Therapeutic | 1 | 2003 | 1412 | 0.050 |
Why?
|
| Receptors, Lipoprotein | 1 | 2003 | 88 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2003 | 182 | 0.050 |
Why?
|
| Electric Countershock | 2 | 1997 | 537 | 0.050 |
Why?
|
| Physical Fitness | 1 | 2006 | 732 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2003 | 375 | 0.050 |
Why?
|
| Stroke Volume | 3 | 2022 | 5523 | 0.050 |
Why?
|
| Genetic Linkage | 2 | 2006 | 2381 | 0.050 |
Why?
|
| Male | 23 | 2023 | 359718 | 0.050 |
Why?
|
| Stents | 1 | 2003 | 3303 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 6316 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2012 | 3620 | 0.050 |
Why?
|
| Exercise | 2 | 2006 | 5787 | 0.050 |
Why?
|
| Catheter Ablation | 5 | 2009 | 2758 | 0.040 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2006 | 819 | 0.040 |
Why?
|
| Middle Aged | 18 | 2023 | 220359 | 0.040 |
Why?
|
| Tachycardia, Ventricular | 1 | 2009 | 1303 | 0.040 |
Why?
|
| Lung | 1 | 2018 | 9994 | 0.040 |
Why?
|
| Female | 22 | 2023 | 391246 | 0.040 |
Why?
|
| Calcium Channel Blockers | 2 | 2012 | 694 | 0.040 |
Why?
|
| Systole | 2 | 2006 | 947 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2007 | 354 | 0.040 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 3880 | 0.040 |
Why?
|
| Adult | 15 | 2024 | 220007 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 4626 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2003 | 1437 | 0.040 |
Why?
|
| Pedigree | 3 | 2006 | 4578 | 0.040 |
Why?
|
| Electrodes | 2 | 1997 | 614 | 0.040 |
Why?
|
| Pacemaker, Artificial | 2 | 2009 | 815 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2024 | 1273 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2003 | 1414 | 0.030 |
Why?
|
| Echocardiography, Stress | 1 | 2017 | 134 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2003 | 1108 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2012 | 1259 | 0.030 |
Why?
|
| Ships | 1 | 2006 | 53 | 0.030 |
Why?
|
| Athletic Injuries | 1 | 2006 | 1209 | 0.030 |
Why?
|
| Confusion | 1 | 2018 | 279 | 0.030 |
Why?
|
| Body Constitution | 1 | 2006 | 273 | 0.030 |
Why?
|
| Aged | 11 | 2022 | 169143 | 0.030 |
Why?
|
| Aged, 80 and over | 6 | 2022 | 58980 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 2003 | 987 | 0.030 |
Why?
|
| Thrombophilia | 1 | 2018 | 307 | 0.030 |
Why?
|
| Aftercare | 1 | 2022 | 916 | 0.030 |
Why?
|
| Electrocardiography | 3 | 2018 | 6415 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 36286 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2006 | 3112 | 0.030 |
Why?
|
| Lod Score | 2 | 2006 | 602 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2006 | 1951 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 13262 | 0.030 |
Why?
|
| Treatment Failure | 2 | 2006 | 2647 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2018 | 1832 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2024 | 3765 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2003 | 6659 | 0.030 |
Why?
|
| Heart Murmurs | 1 | 2003 | 94 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2023 | 80345 | 0.030 |
Why?
|
| Reoperation | 2 | 2003 | 4289 | 0.030 |
Why?
|
| Electric Impedance | 1 | 1997 | 755 | 0.030 |
Why?
|
| Pressure | 1 | 2006 | 1156 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2006 | 901 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2023 | 2629 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2006 | 1377 | 0.030 |
Why?
|
| Exercise Test | 2 | 2006 | 2128 | 0.020 |
Why?
|
| Equipment and Supplies | 1 | 2004 | 275 | 0.020 |
Why?
|
| Prevalence | 2 | 2022 | 15686 | 0.020 |
Why?
|
| Endocarditis, Bacterial | 1 | 2006 | 445 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 1296 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2022 | 2167 | 0.020 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2003 | 227 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 26951 | 0.020 |
Why?
|
| Alcoholism | 1 | 2002 | 1961 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2019 | 4035 | 0.020 |
Why?
|
| Coronary Angiography | 2 | 2003 | 4563 | 0.020 |
Why?
|
| Fever | 1 | 2018 | 1617 | 0.020 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2003 | 265 | 0.020 |
Why?
|
| Syncope | 1 | 2003 | 428 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 2852 | 0.020 |
Why?
|
| Posture | 1 | 2004 | 953 | 0.020 |
Why?
|
| Observer Variation | 1 | 2006 | 2601 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 1296 | 0.020 |
Why?
|
| Family | 2 | 2005 | 3189 | 0.020 |
Why?
|
| Sensitivity and Specificity | 3 | 2010 | 14661 | 0.020 |
Why?
|
| Sex Factors | 1 | 2023 | 10546 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2022 | 3474 | 0.020 |
Why?
|
| Calcium | 1 | 2022 | 5725 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2003 | 5991 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2009 | 10185 | 0.020 |
Why?
|
| Biopsy | 2 | 2010 | 6771 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2012 | 64981 | 0.020 |
Why?
|
| Registries | 1 | 2023 | 8458 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6238 | 0.020 |
Why?
|
| Ventricular Septum | 1 | 2007 | 76 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2004 | 4173 | 0.020 |
Why?
|
| Weight Loss | 1 | 2018 | 2684 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2006 | 8525 | 0.020 |
Why?
|
| Reference Standards | 1 | 2010 | 1004 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2003 | 7850 | 0.020 |
Why?
|
| Disease Progression | 1 | 2023 | 13505 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2006 | 278 | 0.020 |
Why?
|
| Adolescent | 5 | 2006 | 87809 | 0.020 |
Why?
|
| Equipment Design | 1 | 2003 | 3520 | 0.020 |
Why?
|
| Diastole | 1 | 2006 | 788 | 0.010 |
Why?
|
| Heart Valve Prosthesis | 1 | 2003 | 1495 | 0.010 |
Why?
|
| Age Factors | 2 | 2005 | 18413 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 20509 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2023 | 54306 | 0.010 |
Why?
|
| Angiography | 1 | 2009 | 1605 | 0.010 |
Why?
|
| Canada | 1 | 2009 | 2126 | 0.010 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2003 | 84 | 0.010 |
Why?
|
| Prognosis | 2 | 2015 | 29661 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 12968 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2010 | 1431 | 0.010 |
Why?
|
| Receptors, Scavenger | 1 | 2003 | 123 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2006 | 5961 | 0.010 |
Why?
|
| Oxygen | 1 | 2004 | 4193 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 7475 | 0.010 |
Why?
|
| Troponin T | 1 | 2006 | 774 | 0.010 |
Why?
|
| Penetrance | 1 | 2003 | 388 | 0.010 |
Why?
|
| Risk Factors | 3 | 2012 | 74333 | 0.010 |
Why?
|
| Recurrence | 1 | 2003 | 8483 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2003 | 786 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 8552 | 0.010 |
Why?
|
| Advisory Committees | 1 | 2005 | 788 | 0.010 |
Why?
|
| Phenotype | 2 | 2010 | 16548 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2006 | 2609 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2009 | 41337 | 0.010 |
Why?
|
| Defibrillators, Implantable | 1 | 2009 | 1499 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2012 | 3598 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2009 | 2255 | 0.010 |
Why?
|
| Fibrosis | 1 | 2006 | 2042 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15286 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2003 | 882 | 0.010 |
Why?
|
| Comorbidity | 1 | 2003 | 10553 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2003 | 1347 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2003 | 2932 | 0.010 |
Why?
|
| ROC Curve | 1 | 2005 | 3568 | 0.010 |
Why?
|
| Haplotypes | 1 | 2003 | 2764 | 0.010 |
Why?
|
| Sweating | 1 | 1997 | 154 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2003 | 3613 | 0.010 |
Why?
|
| Swine | 1 | 2006 | 5899 | 0.010 |
Why?
|
| Gels | 1 | 1997 | 419 | 0.010 |
Why?
|
| Genotype | 1 | 2010 | 12957 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 15840 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2009 | 12531 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2003 | 2415 | 0.010 |
Why?
|
| Boston | 1 | 2006 | 9278 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1994 | 410 | 0.010 |
Why?
|
| Vasodilation | 1 | 1997 | 962 | 0.010 |
Why?
|
| Massachusetts | 1 | 2005 | 8803 | 0.010 |
Why?
|
| Algorithms | 1 | 2012 | 13982 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2003 | 24102 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2003 | 15679 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 39262 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 1994 | 833 | 0.010 |
Why?
|
| Dogs | 1 | 1994 | 3841 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2003 | 14374 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 2003 | 11481 | 0.000 |
Why?
|
| Animals | 3 | 2006 | 167960 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2003 | 22020 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 17790 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 18137 | 0.000 |
Why?
|
| Young Adult | 1 | 2009 | 58748 | 0.000 |
Why?
|
| United States | 1 | 2009 | 72448 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1997 | 20080 | 0.000 |
Why?
|
| Child | 1 | 2006 | 79799 | 0.000 |
Why?
|
| Mice | 1 | 2003 | 81209 | 0.000 |
Why?
|
| Time Factors | 1 | 1994 | 40139 | 0.000 |
Why?
|